He is a faculty member of ATSU School of Osteopathic Medicine as a Professor of Pediatrics, Neonatal-Perinatal Medicine and Integrative Medicine, Contributor for Pediatrics years 3-4, instructor for Nutrition in Medicine. He is double boarded in Pediatrics and he finished Dr. Andrew Weil’s two year Program in Integrative Medicine under the Department of Family Practice at the University of Arizona Tucson- Class 2006, Board certified in Integrative Medicine. He is a member of COMSEP (Council on Medical Student Education-Pediatrics), AHMA (American Holistic Medical Association), ASCH (the American Society for Clinical Hypnosis), and ABC (America Botanical Council). He has special interests in Botanical Medicine, Environmental Medicine and Mind-Body interactions. He held the position of Clinical Professor of Pediatrics and Neonatology at the University of North Carolina, Chapel Hill and Coastal AHEC (Area Health Education Centers).
He acquired intense molecular/cell biology knowledge and techniques in Dr Louis Pelus’s lab. Most recently, he opted to direct his studies to the pancreatic islet β cell, a cell known to be susceptible to apoptosis, and joined the lab of Dr. Debbie Thurmond, renowned for expertise with islet and skeletal muscle vesicle trafficking mechanisms as they pertain to diabetes. In addition, this training experience further enhanced my research development by acquiring skills in interrogating the cell-specific molecular mechanisms underlying the whole-body physiology of diabetes. 2011 he was awarded a CTSI KL2 Translational Research award and have just submitted his third independent paper as corresponding author. Over the past 10 years his research revealed Pak1 to be a positive effector of pancreatic β-cell function, operating in a novel signaling cascade that is crucial to maintaining whole-body glucose metabolism. Most importantly, data he have generated during the course of my CTSI KL2 independent career award indicates that Pak1 serves as a critical signal-hub for pancreatic β cell survival and replication.
He received a B.S. degree from the University of South Dakota in business administration, a M.P.E. from the University of Nebraska-Lincoln in exercise science, and a Ph.D. from the University of Nebraska-Lincoln in exercise physiology. He is a Professor of Exercise Physiology in the Department of Kinesiology at San Jose State University, Fellow of the American College of Sports Medicine (ACSM), ACSM certified Exercise Test Technologist, National Strength and Conditioning Association (NSCA) Certified Strength and Conditioning Specialist, and NSCA-Certified Personal Trainer. He primarily teaches in the area of exercise physiology and other related exercise science courses.
Dr. Jiulin Wang has both MD and MSc. Degrees in TCM from Nanjing University of Traditional Chinese Medicine, where he was also a faculty member. He has taught TCM/Acupuncture in many universities from China, US, and Canada. Currently, Dr. Jiulin Wang is an associate professor of the Acupuncture Program at Grant MacEwan University. He is also a founding member of Bethune Oriental Medicine Center, a largest Acupuncture clinic in Alberta, where he provides private TCM/Acupuncture service to the public. Jiulin is dedicated to biomedical research. He finished two terms of post-doctoral fellowship training in the Neuroscience Department of Louisiana State University and Oregon Health Science University, USA. He has partnered with the Pulmonary Research Centre, University of Alberta, to finish an Acupuncture research project on COPD. He has published more than 30 professional papers and books.
Since 2001, Jiulin has been an active member of the Acupuncture and TCM profession in Alberta. He was an executive and also secretary in the Acupuncture-TCM Society of Alberta (ASA). Since 2007, he has served as interim council of the College and Association of Acupuncturists of Alberta (CAAA). In 2010, 2012, 2014, he was elected as a CAAA council member, serving as secretary and treasurer separately. He works closely with other council members to accomplish many projects to regulate the profession in the past ten years.
He received his PhD in Biochemistry in 2006 in the field of Molecular Oncology from Edison Institute of Biotechnology, Chemistry and Biochemistry Department, Ohio University in USA. He awarded best publication from Chemistry and Biochemistry Department, Ohio University in 2005. He held postdoctoral position at University of California Berkeley, USA via NIH grant in 2007. He appointed as Head of Molecular therapeutics laboratories at City of Research and Technology in 200. He also received Best Research Award, Global Breast Cancer conference, 2011, Seoul, South Korea and Alexandria University Award for Scientific encouragement in 2012. He awarded international and national grants for discovery of novel small molecules targeting cancer cells; he has many peer reviewed international publications and He is serving in editorial board member in number of international journals.
Clinical biochemistry; Selective anti-cancer drug delivery.